Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 study

J Am Acad Dermatol. 2021 Apr;84(4):1140-1142. doi: 10.1016/j.jaad.2020.06.1004. Epub 2020 Jul 2.

¹ Department of Dermatology and Pediatrics, Department of Dermatology and Pediatrics, University of California, San Diego School of Medicine and Rady Children's Hospital, San Diego, California. Electronic address: leichenfield@rchsd.org.
² Department of Dermatology and Pediatrics, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
³ Department of Dermatology and Pediatrics, University of California, San Francisco, California.
⁴ Department of Dermatology and Pediatrics, Baylor College of Medicine, Houston, Texas.
⁵ Department of Dermatology and Pediatrics, Temple University School of Podiatric Medicine, Philadelphia, Pennsylvania.
⁶ Department of Dermatology and Pediatrics, Mediprobe Research Inc, London, Ontario, Canada; Department of Dermatology and Pediatrics, University of Toronto, Toronto, Ontario, Canada.
⁷ Department of Dermatology and Pediatrics, Bausch Health US, LLC, Petaluma, California.
⁸ Department of Dermatology and Pediatrics, Ortho Dermatologics, Bridgewater, New Jersey. Electronic address: Eric.Guenin@ortho-dermatologics.com.

No abstract available

Publication types